Skip to content

Author

Tianyan Hu

We have 3 of 23 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Quantifying the societal benefits of adult immunization against respiratory diseases in France: a benefit cost analysis.

France's adult respiratory vaccination programs generate positive socioeconomic returns and including adult RSV vaccination and increasing vaccination uptake would further increase their societal benefits.

Matthew Napier, S. Brassel, E. Tunnicliffe et al. · 0 citations
Open access Jul 2026

Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysis.

Spain's adult respiratory vaccination programs generate positive socioeconomic returns and including adult RSV vaccination and increasing vaccination uptake in general could further increase their societal benefits.

Matthew Napier, A. López-Ibáñez de Aldecoa, S. Brassel et al. · 0 citations
Open access Jul 2026

Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysis.

Adult respiratory vaccinations in Sweden provide substantial value for the healthcare system, economy and society, with estimated benefits exceeding costs under modeled assumptions, may inform policy discussions on strategies to sustain or expand vaccination budget, improve access and increase uptake, particularly amon...

E. Tunnicliffe, Matthew Napier, C. Theakston et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.